Current News
September 05, 2014
Directors Nominated By Dissident Shareholder Elected At Annual General Meeting
September 04, 2014
Med BioGene Announces Receipt of Proxies for Upcoming Annual and Special Meeting
August 06, 2014
Med BioGene Announces Director Nominations and Postponement of Annual and Special Meeting
March 07, 2014
Med BioGene Announces Publication of Data Demonstrating Independent Validation of GeneFx® Lung
January 09, 2014
Med BioGene Announces Dismissal of Litigation With Signal Genetics LLC and Respira Health LLC
| Med BioGene engages ir company
Med BioGene announces that the Company has engaged Rick Peterson of Peterson Capital to provide investor relations and business advisory services to the Company. Mr. Peterson has worked in senior roles at leading investment dealers in the Canadian capital markets over the past 25 years, including Midland Walwyn Capital Inc., Merrill Lynch Canada, Yorkton Securities and HSBC Securities. He has significant experience in the venture capital markets, and maintains contact with a wide network of Investment Advisors, institutional salespeople and investment bankers across Canada and in Europe. Mr. Peterson was previously engaged by MBI in the early stages of the development of the GeneFX® Lung commercialization process in securing critical financing for the Company at the time. “I’m thrilled to be joining the Med BioGene team again and helping to develop and execute a capital markets strategy which will benefit every stakeholder in the company, said Mr. Peterson.”The Company will pay Mr. Peterson, through his holding company, Peterson Capital, $5,000/month for a period up to six months and will issue 300,000 stock options to Mr. Peterson at an exercise price of $0.10 which will vest in four equal tranches over the next twelve months.
|
|
© Copyright 2006 - Med BioGene Inc. - Legal Disclaimer